Coldstream Capital Management Inc Legend Biotech Corp Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Coldstream Capital Management Inc holds 144 shares of LEGN stock, worth $4,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
144Holding current value
$4,662% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LEGN
# of Institutions
230Shares Held
84.2MCall Options Held
330KPut Options Held
418K-
Ra Capital Management, L.P. Boston, MA7.51MShares$243 Million3.96% of portfolio
-
Westfield Capital Management CO LP Boston, MA6.92MShares$224 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$218 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$194 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$185 Million0.01% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.42B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...